Accuracy of triage strategies for human papillomavirus DNA-positive women in low-resource settings:A cross-sectional study in China

Objective: Care HPV is a human papillomavirus(HPV) DNA test for low-resource settings(LRS).This study assesses optimum triage strategies for care HPV-positive women in LRS.Methods: A total of 2,530 Chinese women were concurrently screened for cervical cancer with visual inspection with acetic acid(V...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Chinese journal of cancer research 2017-12, Vol.29 (6), p.496-509
Hauptverfasser: Wang, Margaret, Hu, Shangying, Zhao, Shuang, Zhang, Wenhua, Pan, Qinjing, Zhang, Xun, Chen, Feng, Han, Jinxiu, Ma, Junfei, Smith, Jennifer S, Qiao, Youlin, Zhou, Caihong, Zhao, Fanghui
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 509
container_issue 6
container_start_page 496
container_title Chinese journal of cancer research
container_volume 29
creator Wang, Margaret
Hu, Shangying
Zhao, Shuang
Zhang, Wenhua
Pan, Qinjing
Zhang, Xun
Chen, Feng
Han, Jinxiu
Ma, Junfei
Smith, Jennifer S
Qiao, Youlin
Zhou, Caihong
Zhao, Fanghui
description Objective: Care HPV is a human papillomavirus(HPV) DNA test for low-resource settings(LRS).This study assesses optimum triage strategies for care HPV-positive women in LRS.Methods: A total of 2,530 Chinese women were concurrently screened for cervical cancer with visual inspection with acetic acid(VIA),liquid-based cytology and HPV testing by physician-and self-collected care HPV,and physician-collected Hybrid Capture 2(HC2).Screen-positive women were referred to colposcopy with biopsy and endocervical curettage as necessary.HPV-positivity was defined as ≥1.0 relative light units/cutoff(RLU/CO) for both care HPV and HC2.Primary physician-HC2,physician-care HPV and self-care HPV and in sequential screening with cytology,VIA,or increased HPV test-positivity performance,stratified by age,were assessed for cervical intraepithelial neoplasia(CIN) grade 2/3 or worse(CIN2/3+) detection.Results: The sensitivities and specificities of primary HPV testing for CIN2+ were: 83.8%,88.1% for physiciancare HPV; 72.1%,88.2% for self-care HPV; and 97.1%,86.0% for HC2.Physician-care HPV test-positive women with VIA triage had a sensitivity of 30.9% for CIN2+ versus 80.9% with cytology triage.Self-care HPV testpositive women with VIA triage was 26.5% versus 66.2% with cytology triage.The sensitivity of HC2 test-positive women with VIA triage was 38.2% versus 92.6% with cytology triage.The sensitivity of physician-care HPV testing for CIN2+ decreased from 83.8% at ≥1.0 RLU/CO to 72.1% at ≥10.00 RLU/CO,while the sensitivity of selfcare HPV testing decreased from 72.1% at ≥1.0 RLU/CO to 32.4% at ≥10.00 RLU/CO; similar trends were seen with age-stratification.Conclusions: VIA and cytology triage improved specificity for CIN2/3 than no triage.Sensitivity with VIA triage was unsuitable for a mass-screening program.VIA provider training might improve this strategy.Cytology triage could be feasible where a high-quality cytology program exists.Triage of HPV test-positive women by increased test positivity cutoff adds another LRS triage option.
doi_str_mv 10.21147/j.issn.1000-9604.2017.06.04
format Article
fullrecord <record><control><sourceid>wanfang_jour_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5775023</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><cqvip_id>90726589504849554854484852</cqvip_id><wanfj_id>zgazyj201706004</wanfj_id><sourcerecordid>zgazyj201706004</sourcerecordid><originalsourceid>FETCH-LOGICAL-c508t-95636827d9e4ca844ac5c468e489fcc95e07b3a967dabf59ff042d35072c9c7e3</originalsourceid><addsrcrecordid>eNpVkUuP0zAUhSMEYoaBv4C8QIJNwnX8SIzQSFV5SiPYwNpyHSd1ldgdO2nV2fLHcdpOBStfycfn-Nwvy95gKEqMafV-U9gYXYEBIBccaFECrgrgBdAn2TUWguTACX6a5kfJVfYixg0Aqxjg59lVKQgjoiqvsz8Lraeg9AH5Fo3Bqs6gOAY1ms6aiFof0HoalENbtbV97we1s2GK6NOPRb710Y52Z9DeD8Yh61Dv93kw0U9BJxszjtZ18cMC6eBjzKPRo_VO9Slhag7zg-XaOvUye9aqPppX5_Mm-_3l86_lt_zu59fvy8VdrhnUYy4YJ7wuq0YYqlVNqdJMU14bWotWa8EMVCuiBK8atWqZaFugZUMYVKUWujLkJrs9-W6n1WAabVwq2sttsIMKB-mVlf_fOLuWnd9JVqW9lSQZvD0Z7JVrlevkJjVNfaJ86NTDYTODAA5Ak_LdOSr4-8nEUQ42atP3yhk_RYlFLQTmwMsk_XiSHpcUTHv5EAZ5JC43ciYuZ5xyxinnIAlcHpNe_1vq8vgRcRKQs__au-4-EbloRFoNZ7VgQGsqGKM1o2mqWUn-Amo5vDc</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1989916062</pqid></control><display><type>article</type><title>Accuracy of triage strategies for human papillomavirus DNA-positive women in low-resource settings:A cross-sectional study in China</title><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>PubMed Central</source><creator>Wang, Margaret ; Hu, Shangying ; Zhao, Shuang ; Zhang, Wenhua ; Pan, Qinjing ; Zhang, Xun ; Chen, Feng ; Han, Jinxiu ; Ma, Junfei ; Smith, Jennifer S ; Qiao, Youlin ; Zhou, Caihong ; Zhao, Fanghui</creator><creatorcontrib>Wang, Margaret ; Hu, Shangying ; Zhao, Shuang ; Zhang, Wenhua ; Pan, Qinjing ; Zhang, Xun ; Chen, Feng ; Han, Jinxiu ; Ma, Junfei ; Smith, Jennifer S ; Qiao, Youlin ; Zhou, Caihong ; Zhao, Fanghui ; Department of Gynecological Oncology, National Cancer Center/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China ; Department of Cancer Epidemiology, National Cancer Center/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China ; Wuxiang Maternal and Child Health Care and Family Planning Service Center, Changzhi 046300, China ; Department of Epidemiology, University of North Carolina, Chapel Hill, NC 27599-7435, USA ; Xiangyuan Maternal and Child Health Care and Family Planning Service Center, Changzhi 046200, China ; Department of Cytology, National Cancer Center/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China ; UJMT Fogarty Consortium, NIH Fogarty International Center, Bethesda, MD 20892-2220, USA ; Department of Pathology, National Cancer Center/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China ; Department of Education, National Cancer Center/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China ; Pritzker School of Medicine, University of Chicago, Chicago, IL 60637-5415, USA</creatorcontrib><description>Objective: Care HPV is a human papillomavirus(HPV) DNA test for low-resource settings(LRS).This study assesses optimum triage strategies for care HPV-positive women in LRS.Methods: A total of 2,530 Chinese women were concurrently screened for cervical cancer with visual inspection with acetic acid(VIA),liquid-based cytology and HPV testing by physician-and self-collected care HPV,and physician-collected Hybrid Capture 2(HC2).Screen-positive women were referred to colposcopy with biopsy and endocervical curettage as necessary.HPV-positivity was defined as ≥1.0 relative light units/cutoff(RLU/CO) for both care HPV and HC2.Primary physician-HC2,physician-care HPV and self-care HPV and in sequential screening with cytology,VIA,or increased HPV test-positivity performance,stratified by age,were assessed for cervical intraepithelial neoplasia(CIN) grade 2/3 or worse(CIN2/3+) detection.Results: The sensitivities and specificities of primary HPV testing for CIN2+ were: 83.8%,88.1% for physiciancare HPV; 72.1%,88.2% for self-care HPV; and 97.1%,86.0% for HC2.Physician-care HPV test-positive women with VIA triage had a sensitivity of 30.9% for CIN2+ versus 80.9% with cytology triage.Self-care HPV testpositive women with VIA triage was 26.5% versus 66.2% with cytology triage.The sensitivity of HC2 test-positive women with VIA triage was 38.2% versus 92.6% with cytology triage.The sensitivity of physician-care HPV testing for CIN2+ decreased from 83.8% at ≥1.0 RLU/CO to 72.1% at ≥10.00 RLU/CO,while the sensitivity of selfcare HPV testing decreased from 72.1% at ≥1.0 RLU/CO to 32.4% at ≥10.00 RLU/CO; similar trends were seen with age-stratification.Conclusions: VIA and cytology triage improved specificity for CIN2/3 than no triage.Sensitivity with VIA triage was unsuitable for a mass-screening program.VIA provider training might improve this strategy.Cytology triage could be feasible where a high-quality cytology program exists.Triage of HPV test-positive women by increased test positivity cutoff adds another LRS triage option.</description><identifier>ISSN: 1000-9604</identifier><identifier>EISSN: 1993-0631</identifier><identifier>DOI: 10.21147/j.issn.1000-9604.2017.06.04</identifier><identifier>PMID: 29353972</identifier><language>eng</language><publisher>China: UJMT Fogarty Consortium,NIH Fogarty International Center, Bethesda, MD 20892-2220, USA%Department of Cancer Epidemiology, National Cancer Center/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China%Department of Gynecological Oncology, National Cancer Center/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China%Department of Cytology, National Cancer Center/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China%Department of Pathology, National Cancer Center/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021,China%Wuxiang Maternal and Child Health Care and Family Planning Service Center, Changzhi 046300, China%Xiangyuan Maternal and Child Health Care and Family Planning Service Center, Changzhi 046200, China%Department of Epidemiology, University of North Carolina, Chapel Hill, NC 27599-7435, USA%Department of Education, National Cancer Center/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China</publisher><subject>Original</subject><ispartof>Chinese journal of cancer research, 2017-12, Vol.29 (6), p.496-509</ispartof><rights>Copyright © Wanfang Data Co. Ltd. All Rights Reserved.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c508t-95636827d9e4ca844ac5c468e489fcc95e07b3a967dabf59ff042d35072c9c7e3</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Uhttp://image.cqvip.com/vip1000/qk/85190X/85190X.jpg</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC5775023/pdf/$$EPDF$$P50$$Gpubmedcentral$$H</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC5775023/$$EHTML$$P50$$Gpubmedcentral$$H</linktohtml><link.rule.ids>230,314,723,776,780,881,27903,27904,53769,53771</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/29353972$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Wang, Margaret</creatorcontrib><creatorcontrib>Hu, Shangying</creatorcontrib><creatorcontrib>Zhao, Shuang</creatorcontrib><creatorcontrib>Zhang, Wenhua</creatorcontrib><creatorcontrib>Pan, Qinjing</creatorcontrib><creatorcontrib>Zhang, Xun</creatorcontrib><creatorcontrib>Chen, Feng</creatorcontrib><creatorcontrib>Han, Jinxiu</creatorcontrib><creatorcontrib>Ma, Junfei</creatorcontrib><creatorcontrib>Smith, Jennifer S</creatorcontrib><creatorcontrib>Qiao, Youlin</creatorcontrib><creatorcontrib>Zhou, Caihong</creatorcontrib><creatorcontrib>Zhao, Fanghui</creatorcontrib><creatorcontrib>Department of Gynecological Oncology, National Cancer Center/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China</creatorcontrib><creatorcontrib>Department of Cancer Epidemiology, National Cancer Center/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China</creatorcontrib><creatorcontrib>Wuxiang Maternal and Child Health Care and Family Planning Service Center, Changzhi 046300, China</creatorcontrib><creatorcontrib>Department of Epidemiology, University of North Carolina, Chapel Hill, NC 27599-7435, USA</creatorcontrib><creatorcontrib>Xiangyuan Maternal and Child Health Care and Family Planning Service Center, Changzhi 046200, China</creatorcontrib><creatorcontrib>Department of Cytology, National Cancer Center/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China</creatorcontrib><creatorcontrib>UJMT Fogarty Consortium, NIH Fogarty International Center, Bethesda, MD 20892-2220, USA</creatorcontrib><creatorcontrib>Department of Pathology, National Cancer Center/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China</creatorcontrib><creatorcontrib>Department of Education, National Cancer Center/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China</creatorcontrib><creatorcontrib>Pritzker School of Medicine, University of Chicago, Chicago, IL 60637-5415, USA</creatorcontrib><title>Accuracy of triage strategies for human papillomavirus DNA-positive women in low-resource settings:A cross-sectional study in China</title><title>Chinese journal of cancer research</title><addtitle>Chinese Journal of Cancer Research</addtitle><description>Objective: Care HPV is a human papillomavirus(HPV) DNA test for low-resource settings(LRS).This study assesses optimum triage strategies for care HPV-positive women in LRS.Methods: A total of 2,530 Chinese women were concurrently screened for cervical cancer with visual inspection with acetic acid(VIA),liquid-based cytology and HPV testing by physician-and self-collected care HPV,and physician-collected Hybrid Capture 2(HC2).Screen-positive women were referred to colposcopy with biopsy and endocervical curettage as necessary.HPV-positivity was defined as ≥1.0 relative light units/cutoff(RLU/CO) for both care HPV and HC2.Primary physician-HC2,physician-care HPV and self-care HPV and in sequential screening with cytology,VIA,or increased HPV test-positivity performance,stratified by age,were assessed for cervical intraepithelial neoplasia(CIN) grade 2/3 or worse(CIN2/3+) detection.Results: The sensitivities and specificities of primary HPV testing for CIN2+ were: 83.8%,88.1% for physiciancare HPV; 72.1%,88.2% for self-care HPV; and 97.1%,86.0% for HC2.Physician-care HPV test-positive women with VIA triage had a sensitivity of 30.9% for CIN2+ versus 80.9% with cytology triage.Self-care HPV testpositive women with VIA triage was 26.5% versus 66.2% with cytology triage.The sensitivity of HC2 test-positive women with VIA triage was 38.2% versus 92.6% with cytology triage.The sensitivity of physician-care HPV testing for CIN2+ decreased from 83.8% at ≥1.0 RLU/CO to 72.1% at ≥10.00 RLU/CO,while the sensitivity of selfcare HPV testing decreased from 72.1% at ≥1.0 RLU/CO to 32.4% at ≥10.00 RLU/CO; similar trends were seen with age-stratification.Conclusions: VIA and cytology triage improved specificity for CIN2/3 than no triage.Sensitivity with VIA triage was unsuitable for a mass-screening program.VIA provider training might improve this strategy.Cytology triage could be feasible where a high-quality cytology program exists.Triage of HPV test-positive women by increased test positivity cutoff adds another LRS triage option.</description><subject>Original</subject><issn>1000-9604</issn><issn>1993-0631</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2017</creationdate><recordtype>article</recordtype><recordid>eNpVkUuP0zAUhSMEYoaBv4C8QIJNwnX8SIzQSFV5SiPYwNpyHSd1ldgdO2nV2fLHcdpOBStfycfn-Nwvy95gKEqMafV-U9gYXYEBIBccaFECrgrgBdAn2TUWguTACX6a5kfJVfYixg0Aqxjg59lVKQgjoiqvsz8Lraeg9AH5Fo3Bqs6gOAY1ms6aiFof0HoalENbtbV97we1s2GK6NOPRb710Y52Z9DeD8Yh61Dv93kw0U9BJxszjtZ18cMC6eBjzKPRo_VO9Slhag7zg-XaOvUye9aqPppX5_Mm-_3l86_lt_zu59fvy8VdrhnUYy4YJ7wuq0YYqlVNqdJMU14bWotWa8EMVCuiBK8atWqZaFugZUMYVKUWujLkJrs9-W6n1WAabVwq2sttsIMKB-mVlf_fOLuWnd9JVqW9lSQZvD0Z7JVrlevkJjVNfaJ86NTDYTODAA5Ak_LdOSr4-8nEUQ42atP3yhk_RYlFLQTmwMsk_XiSHpcUTHv5EAZ5JC43ciYuZ5xyxinnIAlcHpNe_1vq8vgRcRKQs__au-4-EbloRFoNZ7VgQGsqGKM1o2mqWUn-Amo5vDc</recordid><startdate>20171201</startdate><enddate>20171201</enddate><creator>Wang, Margaret</creator><creator>Hu, Shangying</creator><creator>Zhao, Shuang</creator><creator>Zhang, Wenhua</creator><creator>Pan, Qinjing</creator><creator>Zhang, Xun</creator><creator>Chen, Feng</creator><creator>Han, Jinxiu</creator><creator>Ma, Junfei</creator><creator>Smith, Jennifer S</creator><creator>Qiao, Youlin</creator><creator>Zhou, Caihong</creator><creator>Zhao, Fanghui</creator><general>UJMT Fogarty Consortium,NIH Fogarty International Center, Bethesda, MD 20892-2220, USA%Department of Cancer Epidemiology, National Cancer Center/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China%Department of Gynecological Oncology, National Cancer Center/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China%Department of Cytology, National Cancer Center/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China%Department of Pathology, National Cancer Center/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021,China%Wuxiang Maternal and Child Health Care and Family Planning Service Center, Changzhi 046300, China%Xiangyuan Maternal and Child Health Care and Family Planning Service Center, Changzhi 046200, China%Department of Epidemiology, University of North Carolina, Chapel Hill, NC 27599-7435, USA%Department of Education, National Cancer Center/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China</general><general>Department of Cancer Epidemiology, National Cancer Center/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China</general><general>Pritzker School of Medicine, University of Chicago, Chicago, IL 60637-5415, USA</general><general>AME Publishing Company</general><scope>2RA</scope><scope>92L</scope><scope>CQIGP</scope><scope>~WA</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>2B.</scope><scope>4A8</scope><scope>92I</scope><scope>93N</scope><scope>PSX</scope><scope>TCJ</scope><scope>5PM</scope></search><sort><creationdate>20171201</creationdate><title>Accuracy of triage strategies for human papillomavirus DNA-positive women in low-resource settings:A cross-sectional study in China</title><author>Wang, Margaret ; Hu, Shangying ; Zhao, Shuang ; Zhang, Wenhua ; Pan, Qinjing ; Zhang, Xun ; Chen, Feng ; Han, Jinxiu ; Ma, Junfei ; Smith, Jennifer S ; Qiao, Youlin ; Zhou, Caihong ; Zhao, Fanghui</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c508t-95636827d9e4ca844ac5c468e489fcc95e07b3a967dabf59ff042d35072c9c7e3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2017</creationdate><topic>Original</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Wang, Margaret</creatorcontrib><creatorcontrib>Hu, Shangying</creatorcontrib><creatorcontrib>Zhao, Shuang</creatorcontrib><creatorcontrib>Zhang, Wenhua</creatorcontrib><creatorcontrib>Pan, Qinjing</creatorcontrib><creatorcontrib>Zhang, Xun</creatorcontrib><creatorcontrib>Chen, Feng</creatorcontrib><creatorcontrib>Han, Jinxiu</creatorcontrib><creatorcontrib>Ma, Junfei</creatorcontrib><creatorcontrib>Smith, Jennifer S</creatorcontrib><creatorcontrib>Qiao, Youlin</creatorcontrib><creatorcontrib>Zhou, Caihong</creatorcontrib><creatorcontrib>Zhao, Fanghui</creatorcontrib><creatorcontrib>Department of Gynecological Oncology, National Cancer Center/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China</creatorcontrib><creatorcontrib>Department of Cancer Epidemiology, National Cancer Center/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China</creatorcontrib><creatorcontrib>Wuxiang Maternal and Child Health Care and Family Planning Service Center, Changzhi 046300, China</creatorcontrib><creatorcontrib>Department of Epidemiology, University of North Carolina, Chapel Hill, NC 27599-7435, USA</creatorcontrib><creatorcontrib>Xiangyuan Maternal and Child Health Care and Family Planning Service Center, Changzhi 046200, China</creatorcontrib><creatorcontrib>Department of Cytology, National Cancer Center/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China</creatorcontrib><creatorcontrib>UJMT Fogarty Consortium, NIH Fogarty International Center, Bethesda, MD 20892-2220, USA</creatorcontrib><creatorcontrib>Department of Pathology, National Cancer Center/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China</creatorcontrib><creatorcontrib>Department of Education, National Cancer Center/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China</creatorcontrib><creatorcontrib>Pritzker School of Medicine, University of Chicago, Chicago, IL 60637-5415, USA</creatorcontrib><collection>中文科技期刊数据库</collection><collection>中文科技期刊数据库-CALIS站点</collection><collection>中文科技期刊数据库-7.0平台</collection><collection>中文科技期刊数据库- 镜像站点</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>Wanfang Data Journals - Hong Kong</collection><collection>WANFANG Data Centre</collection><collection>Wanfang Data Journals</collection><collection>万方数据期刊 - 香港版</collection><collection>China Online Journals (COJ)</collection><collection>China Online Journals (COJ)</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Chinese journal of cancer research</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Wang, Margaret</au><au>Hu, Shangying</au><au>Zhao, Shuang</au><au>Zhang, Wenhua</au><au>Pan, Qinjing</au><au>Zhang, Xun</au><au>Chen, Feng</au><au>Han, Jinxiu</au><au>Ma, Junfei</au><au>Smith, Jennifer S</au><au>Qiao, Youlin</au><au>Zhou, Caihong</au><au>Zhao, Fanghui</au><aucorp>Department of Gynecological Oncology, National Cancer Center/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China</aucorp><aucorp>Department of Cancer Epidemiology, National Cancer Center/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China</aucorp><aucorp>Wuxiang Maternal and Child Health Care and Family Planning Service Center, Changzhi 046300, China</aucorp><aucorp>Department of Epidemiology, University of North Carolina, Chapel Hill, NC 27599-7435, USA</aucorp><aucorp>Xiangyuan Maternal and Child Health Care and Family Planning Service Center, Changzhi 046200, China</aucorp><aucorp>Department of Cytology, National Cancer Center/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China</aucorp><aucorp>UJMT Fogarty Consortium, NIH Fogarty International Center, Bethesda, MD 20892-2220, USA</aucorp><aucorp>Department of Pathology, National Cancer Center/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China</aucorp><aucorp>Department of Education, National Cancer Center/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China</aucorp><aucorp>Pritzker School of Medicine, University of Chicago, Chicago, IL 60637-5415, USA</aucorp><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Accuracy of triage strategies for human papillomavirus DNA-positive women in low-resource settings:A cross-sectional study in China</atitle><jtitle>Chinese journal of cancer research</jtitle><addtitle>Chinese Journal of Cancer Research</addtitle><date>2017-12-01</date><risdate>2017</risdate><volume>29</volume><issue>6</issue><spage>496</spage><epage>509</epage><pages>496-509</pages><issn>1000-9604</issn><eissn>1993-0631</eissn><abstract>Objective: Care HPV is a human papillomavirus(HPV) DNA test for low-resource settings(LRS).This study assesses optimum triage strategies for care HPV-positive women in LRS.Methods: A total of 2,530 Chinese women were concurrently screened for cervical cancer with visual inspection with acetic acid(VIA),liquid-based cytology and HPV testing by physician-and self-collected care HPV,and physician-collected Hybrid Capture 2(HC2).Screen-positive women were referred to colposcopy with biopsy and endocervical curettage as necessary.HPV-positivity was defined as ≥1.0 relative light units/cutoff(RLU/CO) for both care HPV and HC2.Primary physician-HC2,physician-care HPV and self-care HPV and in sequential screening with cytology,VIA,or increased HPV test-positivity performance,stratified by age,were assessed for cervical intraepithelial neoplasia(CIN) grade 2/3 or worse(CIN2/3+) detection.Results: The sensitivities and specificities of primary HPV testing for CIN2+ were: 83.8%,88.1% for physiciancare HPV; 72.1%,88.2% for self-care HPV; and 97.1%,86.0% for HC2.Physician-care HPV test-positive women with VIA triage had a sensitivity of 30.9% for CIN2+ versus 80.9% with cytology triage.Self-care HPV testpositive women with VIA triage was 26.5% versus 66.2% with cytology triage.The sensitivity of HC2 test-positive women with VIA triage was 38.2% versus 92.6% with cytology triage.The sensitivity of physician-care HPV testing for CIN2+ decreased from 83.8% at ≥1.0 RLU/CO to 72.1% at ≥10.00 RLU/CO,while the sensitivity of selfcare HPV testing decreased from 72.1% at ≥1.0 RLU/CO to 32.4% at ≥10.00 RLU/CO; similar trends were seen with age-stratification.Conclusions: VIA and cytology triage improved specificity for CIN2/3 than no triage.Sensitivity with VIA triage was unsuitable for a mass-screening program.VIA provider training might improve this strategy.Cytology triage could be feasible where a high-quality cytology program exists.Triage of HPV test-positive women by increased test positivity cutoff adds another LRS triage option.</abstract><cop>China</cop><pub>UJMT Fogarty Consortium,NIH Fogarty International Center, Bethesda, MD 20892-2220, USA%Department of Cancer Epidemiology, National Cancer Center/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China%Department of Gynecological Oncology, National Cancer Center/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China%Department of Cytology, National Cancer Center/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China%Department of Pathology, National Cancer Center/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021,China%Wuxiang Maternal and Child Health Care and Family Planning Service Center, Changzhi 046300, China%Xiangyuan Maternal and Child Health Care and Family Planning Service Center, Changzhi 046200, China%Department of Epidemiology, University of North Carolina, Chapel Hill, NC 27599-7435, USA%Department of Education, National Cancer Center/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China</pub><pmid>29353972</pmid><doi>10.21147/j.issn.1000-9604.2017.06.04</doi><tpages>14</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1000-9604
ispartof Chinese journal of cancer research, 2017-12, Vol.29 (6), p.496-509
issn 1000-9604
1993-0631
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5775023
source Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; PubMed Central
subjects Original
title Accuracy of triage strategies for human papillomavirus DNA-positive women in low-resource settings:A cross-sectional study in China
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-27T17%3A14%3A50IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-wanfang_jour_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Accuracy%20of%20triage%20strategies%20for%20human%20papillomavirus%20DNA-positive%20women%20in%20low-resource%20settings:A%20cross-sectional%20study%20in%20China&rft.jtitle=Chinese%20journal%20of%20cancer%20research&rft.au=Wang,%20Margaret&rft.aucorp=Department%20of%20Gynecological%20Oncology,%20National%20Cancer%20Center/Cancer%20Hospital,%20Chinese%20Academy%20of%20Medical%20Sciences%20and%20Peking%20Union%20Medical%20College,%20Beijing%20100021,%20China&rft.date=2017-12-01&rft.volume=29&rft.issue=6&rft.spage=496&rft.epage=509&rft.pages=496-509&rft.issn=1000-9604&rft.eissn=1993-0631&rft_id=info:doi/10.21147/j.issn.1000-9604.2017.06.04&rft_dat=%3Cwanfang_jour_pubme%3Ezgazyj201706004%3C/wanfang_jour_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1989916062&rft_id=info:pmid/29353972&rft_cqvip_id=90726589504849554854484852&rft_wanfj_id=zgazyj201706004&rfr_iscdi=true